HOYA (OTCMKTS:HOCPY - Get Free Report) will likely be releasing its earnings data on Thursday, February 6th. Analysts expect HOYA to post earnings of $0.01 per share and revenue of $218.60 billion for the quarter.
HOYA Stock Down 0.3 %
OTCMKTS HOCPY traded down $0.42 during midday trading on Thursday, hitting $136.59. 13,896 shares of the company traded hands, compared to its average volume of 24,471. HOYA has a 52 week low of $108.12 and a 52 week high of $148.27. The company's 50-day simple moving average is $130.11 and its 200-day simple moving average is $132.51. The company has a market cap of $47.58 billion, a PE ratio of 36.62, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.14 and a quick ratio of 4.43.
HOYA Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Recommended Stories
Before you consider HOYA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HOYA wasn't on the list.
While HOYA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.